Physician profile
Bryan Duell
NPI 1376078543
$3,538.50
in general payments reported to CMS, 2019-2025
14 companies · $313 in 2025
The $313 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,750 · 2023: $187 · 2024: $290 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $2,656.87 | 2022-2025 | |
| Stryker Corporation | $161.95 | 2022-2024 | Triathlon |
| Abbvie INC. | $152.95 | 2022-2024 | Dalvance, Avycaz, Teflaro |
| Depuy Synthes Sales INC. | $141.13 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $62.40 | 2023-2025 | Zilretta, Exparel, Iovera |
| P Bar Medical LLC | $62.18 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $55.36 | 2025 | |
| Amgen INC. | $54.39 | 2023-2024 | Prolia, Evenity |
| Heron Therapeutics, INC. | $47.80 | 2024-2025 | Zynrelef |
| Dynasplint Systems INC. | $35.97 | 2024 | Dynasplint |
| Smith+Nephew, INC. | $34.47 | 2024 | Bone Anchors With Arthroscopic Delivery System |
| Bioventus LLC | $32.91 | 2024-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Horizon Therapeutics Plc | $23.58 | 2023 | Krystexxa |
| Solventum Corporation | $16.54 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Duell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.